Pak Fah Yeow International Limited (HKG:0239)
Hong Kong
· Delayed Price · Currency is HKD 2.340
+0.010 (0.43%)
At close: Mar 10, 2026
HKG:0239 Revenue
Pak Fah Yeow International had revenue of 94.96M HKD in the half year ending June 30, 2025, a decrease of -25.00%. This brings the company's revenue in the last twelve months to 199.55M, down -24.92% year-over-year. In the year 2024, Pak Fah Yeow International had annual revenue of 237.43M, down -8.53%.
Revenue (ttm)
199.55M
Revenue Growth
-24.92%
P/S Ratio
3.65
Revenue / Employee
2.00M
Employees
100
Market Cap
729.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 237.43M | -22.13M | -8.53% |
| Dec 31, 2023 | 259.56M | 111.81M | 75.68% |
| Dec 31, 2022 | 147.75M | 7.22M | 5.14% |
| Dec 31, 2021 | 140.53M | 30.77M | 28.03% |
| Dec 31, 2020 | 109.76M | -38.53M | -25.98% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fusen Pharmaceutical Company | 264.08M |
| Lee's Pharmaceutical Holdings | 1.44B |
| Zhongzhi Pharmaceutical Holdings | 2.20B |
| China NT Pharma Group Company | 20.45M |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.02B |
| Chia Tai Enterprises International | 4.17B |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| Dawnrays Pharmaceutical (Holdings) | 1.22B |